Simcere Pharmaceutical Group Limited
2096
Pozycja w akcjach
#4480
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
Cena akcji
$1.32
Kapitalizacja rynkowa
$3.40B
Zmiana (1 dzień)
-4.51%
Zmiana (1 rok)
-19.88%
Kraj
CN
Handel Simcere Pharmaceutical Group Limited (2096)
Kategoria
Healthcare
Historia dywidend dla Simcere Pharmaceutical Group Limited (2096)
Simcere Pharmaceutical Group Limited (symbol giełdowy: 2096) wypłaciła łącznie 6 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): $1.09
Wskaźnik dywidendy (TTM): 0.0199
Suma wszystkich dywidend (skorygowana o podziały akcji): $1.09
Wskaźnik dywidendy (TTM): 0.0199
Wypłaty dywidend dla Simcere Pharmaceutical Group Limited (2096) od 2021 do 2026
Roczne wypłaty dywidend
| Rok | Dywidenda (skorygowana o podziały akcji) | Zmień |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
Lista wszystkich wypłat dywidend
| Rok | Dywidenda | Zmień |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
Wypłaty dywidend firm podobnych lub konkurencyjnych
| Firma | Liczba wypłat dywidend | Kraj |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 0.00% |
NL
|
|
| 30.00% |
BE
|
